Solifenacin for overactive bladder: a systematic review and meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Obstetrics and Gynecology
Link
http://link.springer.com/content/pdf/10.1007/s00192-011-1641-7.pdf
Reference31 articles.
1. Abrams P, Cardozo L, Fall M et al (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation subcommittee of the International Continence Society. Urology 61(1):37–49
2. Milsom I, Abrams P, Cardozo L et al (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87(9):760–766
3. Chapple CR (2007) Advancing the management of overactive bladder: new data, new directions. Eur Urol Suppl 6:1–3
4. Reeves P, Irwin D, Kelleher C et al (2006) The current and future burden and cost of overactive bladder in five European countries. Eur Urol 50:1050–1057
5. Hampel C (2007) Long-term management of overactive bladder with antimuscarinic agents. Eur Urol Suppl 6:432–437
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical practice guideline for acupuncture and moxibustion: Female urinary incontinence;Journal of Integrative Medicine;2024-05
2. The effect of solifenacin treatment for urge urinary incontinence on sexual function in premenopausal and postmenopausal women: a prospective observational study;Cukurova Medical Journal;2023-03-31
3. New approaches to treatments for sleep, pain and autonomic failure in Parkinson's disease - Pharmacological therapies;Neuropharmacology;2022-05
4. The Effectiveness in Activating M-Type K+ Current Produced by Solifenacin ([(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate): Independent of Its Antimuscarinic Action;International Journal of Molecular Sciences;2021-11-17
5. Evaluation of the Clinical Efficacy and Complications of Duloxetine in Comparison to Solifenacin in the Treatment of Overactive Bladder Disease in Women: A Randomized Clinical Trial;UROL J;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3